Search Site


Answer Centre - Telephone Answering in your Company Name by an Answer Centre PA


Stem Cell Sciences in diabetes R&D agreement

24 December 2007

Stem Cell Sciences the biotechnology company working to commercialise stem cells and stem cell technologies in research, has signed a contract research agreement with a major biopharmaceutical company.

Under the terms of the agreement Stem Cell Sciences will validate its suite of cell processing technologies for the scaled, automated production of human embryonic stem cells (ES) and demonstrate the bulk production of cells relevant for diabetes research at the company's Cambridge based production facility.

Financial terms of the agreement were not disclosed.

Stem Cell Sciences said it intended to seek similar agreements in the future with biopharmaceutical companies as the field of stem cell-based therapeutics expands.






Headlines

31 August 2010

30 August 2010

27 August 2010

20 August 2010

18 August 2010

13 August 2010

09 August 2010

06 August 2010

30 July 2010

29 July 2010

28 July 2010

27 July 2010

26 July 2010

23 July 2010

23 July 2010

22 July 2010

21 July 2010

19 July 2010

16 July 2010

12 July 2010

09 July 2010

08 July 2010

07 July 2010

06 July 2010

05 July 2010

02 July 2010

06 May 2010

13 April 2010

24 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

19 March 2010

19 March 2010

» See all News




© SmallCapNews   |   Contact Us   |   Terms of Use   |   RSS Feeds Site by LunarSafari